HBIOX Performance — Hartford International Opportunities Hls Fund, Class IB
Data updated: 2026-08-28
HBIOX returned +10.71% year to date and +21.59% over one year to Jun 2026. Annualised returns are +17.10% over 3 years and +7.57% over 5 years. The fund trailed its International Multi-Cap Blend category average: $100 invested three years ago grew to $161, against $162 for the category, and to $122 over one year, against $122. Volatility over the past three years was 12.51% a year. In the 12 months to Jun 2026 the fund lost a net $83.3M, and assets reached $870.34M.
HBIOX Growth of $100
What $100 invested in Hartford International Opportunities Hls Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Multi-Cap Blend category average over the same months.
| Period | HBIOX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $122 | $122 |
| 3 years (Jul 2023 – Jun 2026) | $161 | $162 |
| 5 years (Jul 2021 – Jun 2026) | $144 | $154 |
| Since data start (Jul 2019 – Jun 2026) | $195 | $200 |
HBIOX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.71% |
| 1 year | +21.59% |
| 3 years (annualised) | +17.10% |
| 5 years (annualised) | +7.57% |
HBIOX Annual Returns
Calendar-year total returns of Hartford International Opportunities Hls Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +10.71% |
| 2025 | +30.06% |
| 2024 | +8.09% |
| 2023 | +11.44% |
| 2022 | −18.33% |
| 2021 | +7.56% |
| 2020 | +20.10% |
| 2019 (Jul–Dec) | +6.37% |
HBIOX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.3% | +4.0% | −8.8% | +8.1% | +3.5% | 0.0% | — | — | — | — | — | — |
| 2025 | +4.5% | +2.3% | −0.7% | +2.9% | +5.1% | +3.1% | −2.7% | +4.3% | +3.2% | +0.8% | +1.4% | +2.6% |
| 2024 | −1.4% | +3.0% | +3.9% | −1.3% | +4.7% | −0.7% | +1.6% | +3.5% | +0.5% | −4.1% | +1.2% | −2.8% |
| 2023 | +8.4% | −4.8% | +2.1% | +0.9% | −3.0% | +4.6% | +2.7% | −5.5% | −3.4% | −1.8% | +7.8% | +3.9% |
| 2022 | −4.7% | −3.3% | −0.5% | −7.4% | +1.6% | −8.8% | +4.0% | −4.4% | −9.3% | +3.0% | +13.8% | −1.8% |
| 2021 | −1.4% | +2.9% | −0.6% | +3.3% | +2.2% | −0.7% | −0.4% | +3.0% | −3.8% | +3.8% | −4.0% | +3.4% |
| 2020 | −2.4% | −5.2% | −15.9% | +6.9% | +5.1% | +7.6% | +6.4% | +4.1% | −1.6% | −1.1% | +11.8% | +6.0% |
| 2019 | — | — | — | — | — | — | −1.8% | −1.6% | +0.8% | +3.1% | +1.4% | +4.4% |
HBIOX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.51%
- 3-year Sharpe ratio: 1.01 (vs 4.5% risk-free rate)
- Best month: +8.13% (Apr 2026)
- Worst month: −8.82% (Mar 2026)
HBIOX Fund Flows
Monthly money in and out of Hartford International Opportunities Hls Fund, from SEC Form N-PORT.
- 12-month net flow: −$83.3M
- 12-month gross sales (incl. reinvestments): $72.0M
- Sales ÷ redemptions: 0.46×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.9M | $10.8M | −$7.9M |
| May 2026 | $5.1M | $14.5M | −$9.4M |
| Apr 2026 | $3.1M | $12.6M | −$9.5M |
| Mar 2026 | $4.7M | $12.0M | −$7.3M |
| Feb 2026 | $5.9M | $19.1M | −$13.1M |
| Jan 2026 | $5.6M | $13.9M | −$8.3M |
| Dec 2025 | $4.9M | $13.4M | −$8.6M |
| Nov 2025 | $2.2M | $10.8M | −$8.6M |
| Oct 2025 | $4.2M | $14.9M | −$10.7M |
| Sep 2025 | $4.8M | $8.3M | −$3.5M |
| Aug 2025 | $22.8M | $9.2M | $13.6M |
| Jul 2025 | $5.7M | $15.7M | −$10.0M |
HBIOX Assets Under Management
Net assets of Hartford International Opportunities Hls Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $870.34M |
| 2026-03-31 | $801.89M |
| 2025-12-31 | $837.78M |
| 2025-09-30 | $826.62M |
| 2025-06-30 | $806.85M |
| 2025-03-31 | $860.48M |
| 2024-12-31 | $825.91M |
| 2024-09-30 | $898.60M |
| 2024-06-30 | $874.00M |
| 2024-03-31 | $880.29M |
| 2023-12-31 | $874.14M |
| 2023-09-30 | $813.01M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.